Literature DB >> 22886470

Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.

Emilio Besada1, Rune Johan Njålla, Johannes C Nossent.   

Abstract

We report a case of visceral leishmaniasis in a patient from northern Norway with psoriatic arthritis treated with a combination of etanercept and methotrexate. The patient resided extensively in southern Spain, a zone endemic for leishmania.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22886470     DOI： 10.1007/s00296-012-2483-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  14 in total

1.  A 15-month-old girl with fever and pancytopenia.

Authors:  Marius Kurås Skram; Sidsel Bjering; Nils Olav Hermansen; Leigh Dini; Marit Hellebostad
Journal:  Tidsskr Nor Laegeforen       Date:  2011-12-13

Review 2.  Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.

Authors:  F De Leonardis; M Govoni; A Lo Monaco; F Trotta
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

3.  Cryoglobulinemic purpura in visceral leishmaniasis.

Authors:  Evangelos Rizos; George Dimos; Evangelos N Liberopoulos; Moses S Elisaf; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

4.  Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection.

Authors:  Erik Ahlin; Amir Elshafei; Musa Nur; Sayda Hassan El Safi; Ronnelid Johan; Gehad Elghazali
Journal:  Rev Bras Reumatol       Date:  2011-12

5.  Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus.

Authors:  Lazaros I Sakkas; Maria Boulbou; Despina Kyriakou; Irene Makri; Chrysanthi Sinani; Anastasios Germenis; Nikolaos Stathakis
Journal:  Clin Biochem       Date:  2007-10-25       Impact factor: 3.281

6.  [Leishmaniases in France: an update].

Authors:  P Marty; C Pomares-Estran; L Hasseine; P Delaunay; H Haas; E Rosenthal
Journal:  Arch Pediatr       Date:  2009-10       Impact factor: 1.180

7.  Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy.

Authors:  G Castellino; M Govoni; A Lo Monaco; C Montecucco; F Colombo; F Trotta
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  A leishmanin skin test survey in the human population of l'Alacantí region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe.

Authors:  L Moral; E M Rubio; M Moya
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Mar-Apr       Impact factor: 2.184

9.  Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.

Authors:  Aeesha N J Malik; Lawrence John; Anthony D M Bruceson; Diana N J Lockwood
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

Review 10.  Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.

Authors:  Ioannis D Xynos; Maria G Tektonidou; Dimitrios Pikazis; Nikolaos V Sipsas
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883
View more
  6 in total

1.  CD4+ T Cells Alter the Stromal Microenvironment and Repress Medullary Erythropoiesis in Murine Visceral Leishmaniasis.

Authors:  Olivier Preham; Flaviane A Pinho; Ana Isabel Pinto; Gulab Fatima Rani; Najmeeyah Brown; Ian S Hitchcock; Hiro Goto; Paul M Kaye
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

2.  Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.

Authors:  Pau Bosch-Nicolau; Maria Ubals; Fernando Salvador; Adrián Sánchez-Montalvá; Gloria Aparicio; Alba Erra; Pablo Martinez de Salazar; Elena Sulleiro; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30

3.  Effect of immunosuppressants on the parasite load developed in, and immune response to, visceral leishmaniasis: A comparative study in a mouse model.

Authors:  Lorena Bernardo; Jose Carlos Solana; Alba Romero-Kauss; Carmen Sánchez; Eugenia Carrillo; Javier Moreno
Journal:  PLoS Negl Trop Dis       Date:  2021-02-01

Review 4.  Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.

Authors:  John M Curtin; Naomi E Aronson
Journal:  Microorganisms       Date:  2021-03-11

Review 5.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16

Review 6.  Ocular Parasitosis Caused by Protozoan Infection during Travel: Focus on Prevention and Treatment.

Authors:  Morteza Izadi; Mohsen Pourazizi; Mahmoud Babaei; Ali Saffaei; Mohammad-Hasan Alemzadeh-Ansari
Journal:  Int J Prev Med       Date:  2018-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.